GDF-15 improves the predictive capacity of steatotic liver disease non-invasive tests for incident morbidity and mortality risk for cardio-renal-metabolic diseases and malignancies
The herein-developed GDF-15 enhanced indices demonstrate higher screening effectiveness and significantly improved prognostic abilities, which are reduced to practice through an easy-to-use web-based calculator tool (https://clinicalpredictor.shinyapps.io/multimorbidity-mortality-risk/).
Authors
- Pytrik Folkertsma (ORCID: https://orcid.org/0000-0003-1823-8706)
- Christos Socrates Mantzoros (ORCID: https://orcid.org/0000-0003-3755-8158)
- Sipko van Dam (ORCID: https://orcid.org/0000-0001-9204-0197)
- Bruce H. R. Wolffenbuttel (ORCID: https://orcid.org/0000-0001-9262-6921)
- José Castela Forte (ORCID: https://orcid.org/0000-0001-9273-0702)
- Michail Kokkorakis (ORCID: https://orcid.org/0000-0002-0027-5659)
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
Publication Details
- Journal
- Metabolism
- Published
- 2024-10-12
- DOI
- https://doi.org/10.1016/j.metabol.2024.156047
- Citations
- 6
- Primary Topic
- GDF15 and Related Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 2.82
Funders
- Massachusetts Life Sciences Center
- Universitair Medisch Centrum Groningen